Free Newsletter
U.K. reseachers dream up chemo combo drug delivery alternative
Most chemotherapy drugs are still delivered to the body through an intravenous drip over several hours or by injection, both tedious and painful exercises. Researchers from the University of Bradford are trying to change that. In a test, they plan to adapt an unnamed chemotherapy drug's chemical structure to make a new "carrier molecule." Scientists will then attach it to other established drugs—in either a tablet or capsule—which would allow patients to swallow the treatment, like an aspirin. To be determined: If the combined chemo drug/delivery system would distribute the treatment more effectively. What is hoped for: an efficient alternative that reduces side effects and offers patients a simpler chemotherapy option. Release
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline

SHARE
WITH: